Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20180728001Recruiting
Randomised, open-label trial of ropivacaine in None (2 arms), sponsored by none. Primary endpoint: Posterior knee pain intensity. Started Aug 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20180728001.